A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
Recruiting · NCT07472491 · Registry updated 2026-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients | Known or Highly Suspected Body (Excluding CNS) Lesion; Known or Highly Suspected Central Nervous System (CNS) Lesion | Recruiting | Phase 2 / Phase 3 | 2026-06-29 | NCT07472491 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GE Healthcare | 47 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arensia Exploratory Medicine - Moldova - IMSP Spitalul Clinic Republican Timofei Mosneaga | Chisinau | Moldova | 1 |
| LLC Todua Clinic | Tbilisi | Georgia | 4 |
| LTD Israel-Georgian Medical Research Clinic Healthycore | Tbilisi | Georgia | 1 |
| LTD New Hospitals | Tbilisi | Georgia | 13 |
| Mayo Clinic | Rochester | United States | 664 |
| Renovatio Clinical | The Woodlands | United States | 20 |
| Seoul National University Hospital | Seoul | South Korea | 393 |